Latest News

Friday, February 24, 2017 | Conferences,Glaucoma, Inotek Pharmaceuticals

Inotek Pharmaceuticals Announces Poster Presentations on Trabodenoson at the American Glaucoma Society 2017 Annual Meeting

Inotek Pharmaceuticals announced three poster presentations at the American Glaucoma Society 2017 Annual Meeting to be held March 2-5 in Coronado, California. The presentation details are as follows: …

Read the full story

Friday, February 24, 2017 | Partnerships

Sterling Partners Announces Strategic Partnership with Grand Rapids Ophthalmology

Sterling Partners announced that it has partnered with Grand Rapids Ophthalmology (GRO), a comprehensive eye care provider offering ophthalmology, optometry, and retail optical services throughout Wes…

Read the full story

Friday, February 24, 2017 | Glaucoma,Medical Studies

Surgical Techniques Showcased at Glaucoma Meeting

A new analysis of 5-year pooled data from two studies, along with highly anticipated reports on new surgical techniques, will be in the spotlight at the upcoming American Glaucoma Society (AGS) 2017 A…

Read the full story

Thursday, February 23, 2017 | Clinical Trials,Medical Studies

ToolGen Highlights Study Results Demonstrating Utility of AAV-Compatible Cas9 System In Vivo Genome Editing

ToolGen announced encouraging data from a study evaluating Campylobacter jejuni Cas9 (CjCas9), the smallest Cas9 orthologue characterized to date, for efficient genome editing in vivo, according to a …

Read the full story

Thursday, February 23, 2017 | Health Care, Allergan

Allergan CEO Pushes for Trump to Lead Drug Price Discussions

When asked about President Trump’s calls to deal with high US drug costs, Allergan Chief Executive Officer Brent Saunders told Bloomberg News that President Trump should lead negotiations with d…

Read the full story

Thursday, February 23, 2017 | Conferences

General Sessions at the ASCRS-ASOA Symposium and Congress

The American Society of Cataract and Refractive Surgery (ASCRS) Symposium and American Society of Ophthalmic Administrators (ASOA) Congress will feature internationally renowned presenters during the …

Read the full story

Thursday, February 23, 2017 | Glaucoma,Partnerships, Santen

Santen and twoXAR Announce Strategic Research Collaboration to Discover New Glaucoma Treatments

Santen and twoXAR, an artificial intelligence-driven biopharmaceutical company, announced that the two companies have entered into a strategic research collaboration focused on the identification of n…

Read the full story

Thursday, February 23, 2017 | Miscellaneous, Calhoun Vision

Calhoun Vision Becomes RxSight

Calhoun Vision announced that it has formally changed its name to RxSight. The company also announced the filing of its initial premarket approval with the FDA as well as the addition of veteran healt…

Read the full story

Thursday, February 23, 2017 | Partnerships, Alimera Sciences

Alimera Sciences and Knight Therapeutics Announce Filing of New Drug Submission for Iluvien in Canada

Alimera Sciences and Knight Therapeutics, a Canadian specialty pharmaceutical company, announced that Knight's New Drug Submission (NDS) for Iluvien has been accepted for review by Health Canada. …

Read the full story

Thursday, February 23, 2017 | Medical Studies

First ADA Guidance on Diabetic Retinopathy in 15 Years

A new retinopathy position statement from the American Diabetes Association (ADA) reflects the "dramatic" improvements in both assessment and treatment in the 15 years since ADA's last g…

Read the full story

Wednesday, February 22, 2017 | Management/Leadership, Glaukos Corporation

L. Jay Katz, MD, Joins Glaukos Corporation as Chief Medical Officer

Glaukos announced that L. Jay Katz, MD, FACS, has joined the company as Chief Medical Officer. Dr. Katz is currently a practicing ophthalmologist, the Director of Glaucoma Service at Wills Eye Hospita…

Read the full story

Wednesday, February 22, 2017 | Product Releases, Topcon Medical Systems

Topcon Introduces the SL-D301 Slit Lamp With Three Magnifications, Photo, and Video Capability

Topcon Medical Systems has announced the release of the new SL-D301 Slit Lamp, a clinical slit lamp that covers all aspects of an eye examination. It has a tower illumination system with a halogen bul…

Read the full story

Wednesday, February 22, 2017 | Product Releases

IBM is Training Watson to Identify Retina Abnormalities

IBM Research announced new developments in IBM Watson's ability to detect abnormalities of the retina. The Melbourne, Australia-based IBM researchers have trained a research version of Watson to r…

Read the full story

Wednesday, February 22, 2017 | Cataract Surgery, Ocular Therapeutix

Ocular Therapeutix Announces FDA Acceptance of NDA Resubmission for Dextenza for the Treatment of Ocular Pain After Ophthalmic Surgery

Ocular Therapeutix announced that the company’s new drug application (NDA) resubmission for Dextenza (dexamethasone insert) 0.4 mg for intracanalicular use for the treatment of ocular pain occur…

Read the full story

Wednesday, February 22, 2017 | Medical Studies, Alimera Sciences

Iluvien Implants Yield 12-month Benefit for Diabetic Macular Edema

The anatomical and visual benefits of intravitreal fluocinolone acetonide implants in patients with chronic diabetic macular edema (DME) persist up to 12 months, a small study suggests. The efficacy a…

Read the full story
Load More